E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers T > Headlines for T2 Biosystems, Inc. > News item
Published on 12/1/2015 in the Prospect News PIPE Daily.

T2 Biosystems plans to price public sale of 3.5 million common shares

Goldman Sachs, Leerink, Canaccord Genuity, Cantor Fitzgerald assist

By Devika Patel

Knoxville, Tenn., Dec. 1 – T2 Biosystems, Inc. said it will conduct a public offering of 3.5 million common shares with a 30-day greenshoe of 525,000 additional shares.

Goldman Sachs & Co. is the bookrunner. Leerink Partners LLC, Canaccord Genuity Inc. and Cantor Fitzgerald & Co. will be underwriters.

The in vitro diagnostics company is based in Lexington, Mass.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.